MoneyWorks4Me

Sun Pharma Advanced Research Company informs about press release

03 Dec 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed a Press Release on December 03, 2021 titled ‘SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 45.94
Prime Focus 352.35
Knowledge RealtyTrt. 113.71
Indegene 596.10
Syngene Internatl. 385.35
View more..